Lupin, Mylan to commercialize Enbrel Biosimilar
Under the terms of the agreement, Lupin will receive an up-front payment of $15 million.
Pharma major Lupin Limited and global pharmaceutical company Mylan have a...
From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment
Continue readingAdvertisement
Advertisement
Advertisement
Advertisement
Advertisement